HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.

AbstractOBJECTIVE:
To examine the potential value of maternal serum concentration of placental protein 13 (PP13) at 11-13 weeks' gestation in screening for preeclampsia (PE).
METHODS:
Serum PP13, PAPP-A and uterine artery pulsatility index (PI) were determined in a case-control study of 208 cases that developed PE including 48 that required delivery before 34 weeks (early-PE) and 416 unaffected controls.
RESULTS:
Serum PP13 levels, expressed as multiples of the median (MoM) in the unaffected group, were significantly reduced in early-PE (0.83 MoM) but not in late-PE (0.96 MoM). In both early- and late-PE serum PAPP-A (0.55 and 0.84 MoM) was reduced and uterine artery PI (1.61 and 1.25 MoM) was increased. In PE pregnancies there was a significant association between serum PP13 and both uterine artery PI and serum PAPP-A (p < 0.0001 for both). Logistic regression analysis demonstrated that serum PP13 did not improve significantly the prediction of early-PE provided by a combination of maternal factors, uterine artery PI and PAPP-A.
CONCLUSION:
PP13 is implicated in the pathogenesis of impaired placentation and subsequent development of early-PE but measurement of this placental product is unlikely to be useful in screening for the disease at 11-13 weeks.
AuthorsRanjit Akolekar, Argyro Syngelaki, Jarek Beta, Rafal Kocylowski, Kypros H Nicolaides
JournalPrenatal diagnosis (Prenat Diagn) Vol. 29 Issue 12 Pg. 1103-8 (Dec 2009) ISSN: 1097-0223 [Electronic] England
PMID19777530 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Galectins
  • LGALS13 protein, human
  • Pregnancy Proteins
  • Pregnancy-Associated Plasma Protein-A
Topics
  • Age of Onset
  • Case-Control Studies
  • False Positive Reactions
  • Female
  • Galectins (blood)
  • Gestational Age
  • Humans
  • Mothers
  • Placentation (physiology)
  • Pre-Eclampsia (blood, diagnosis, epidemiology, etiology)
  • Pregnancy
  • Pregnancy Proteins (blood)
  • Pregnancy Trimester, First (blood)
  • Pregnancy-Associated Plasma Protein-A (analysis)
  • Prenatal Diagnosis
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: